Skip to main content

Table 1 Baseline characteristics of the patients

From: Incidence and influence of prosthesis-patient mismatch after reoperative aortic valve replacement: a retrospective single-center study

 

Total

(n = 113)

Repeat AVR

(n = 44)

Primary AVR

(n = 69)

p

Male (%)

54 (47.8)

22 (50)

54 (78.3)

0.85

Age (years)

68.4 ± 12.8

70.4 ± 13.7

67.2 ± 12.1

0.2

Body mass index

22.5 ± 4.1

22.7 ± 4.9

22.4 ± 3.6

0.68

Body surface area

1.5 ± 0.2

1.5 ± 0.2

1.5 ± 0.2

0.81

Diabetes (%)

26 (23)

9 (20.5)

17 (24.6)

0.65

Hypertension (%)

61 (54)

26 (59.1)

35 (50.7)

0.44

Dyslipidemia (%)

38 (33.6)

14 (31.8)

24 (34.8)

0.84

Smoking history (%)

30 (26.5)

12 (27.3)

18 (26.1)

1

COPD (%)

15 (13.3)

7 (15.9)

8 (11.6)

0.58

Atrial fibrillation (%)

20 (17.7)

5 (11.4)

15 (21.7)

0.21

CVD (%)

15 (13.3)

3 (6.8)

5 (7.2)

1

Low LVEF < 40% (%)

7 (6.2)

3 (6.8)

4 (5.8)

1

Emergency (%)

3 (2.7)

2 (4.5)

1 (1.4)

0.56

Hemodialysis

10 (8.8)

5 (11.4)

5 (7.2)

0.51

Endocarditis

12 (10.6)

8 (18.2)

4 (5.8)

0.06

Aortic stenosis

70 (61.9)

23 (52.3)

47 (68.1)

0.11

Interval since last cardiac surgery (y)

13.9 ± 9.4

11 ± 8.1

15.7 ± 9.8

0.01

Reoperations

   

0.33

 First reoperation

102 (90.3)

38 (86.4)

64 (92.8)

 

 Second reoperation

11 (9.7)

6 (13.6)

5 (7.2)

 
  1. AVR aortic valve replacement, COPD chronic obstructive pulmonary disease, CVD cerebrovascular disease, LVEF left ventricle ejection fraction